Farshad Guirakhoo
Technik-/Wissenschafts-/F&E-Leiter bei EXPRES2ION BIOTECH HOLDING AB
Profil
Farshad Guirakhoo is the founder of Responsive Bioservices LLC, which was founded in 2017.
He is currently the Chief Scientific Officer at Expres2ion Biotech Holding AB since 2023.
Dr. Guirakhoo's former jobs include Senior Director-External Research & Development at Sanofi Pasteur, Inc. from 2007 to 2012, Senior Director & Head-Virology Research at Acambis, Inc. from 1992 to 2007, Chief Scientific Officer at GeoVax, Inc. from 2015 to 2020, Chief Technology Officer at Vaxess Technologies, Inc. from 2014 to 2015, Chief Scientific Officer at GeoVax Labs, Inc. from 2015 to 2020, and Chief Scientific Officer at Hookipa Biotech AG from 2012 to 2014.
Dr. Guirakhoo's education includes a doctorate from the University of Vienna and a graduate degree from the University of Tehran.
Aktive Positionen von Farshad Guirakhoo
| Unternehmen | Position | Beginn |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Technik-/Wissenschafts-/F&E-Leiter | 16.01.2023 |
Ehemalige bekannte Positionen von Farshad Guirakhoo
| Unternehmen | Position | Ende |
|---|---|---|
| GEOVAX LABS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 10.08.2020 |
GeoVax, Inc.
 GeoVax, Inc. BiotechnologyHealth Technology Part of GeoVax Labs, Inc., GeoVax, Inc. develops biotechnology and vaccines. The company is based in Smyrna, GA. GeoVax was acquired by Dauphin Technology, Inc. on October 03, 2006. The company was founded in 2001 by Harriet Latham Robinson. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2020 |
| Responsive Bioservices LLC | Vorstandsvorsitzender | 01.06.2020 |
Vaxess Technologies, Inc.
 Vaxess Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Vaxess Technologies, Inc. provides global vaccine access distribution services. It develops a pipeline of next-generation MIMIX therapies. The firm provides MIMIX oncology and MIMIX infectious disease. The company was founded by Patrick Ho, David Kaplan, Kathryn Kosuda, Fiorenzo Omenetto, Michael Schrader and Livio Valenti in 2012 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2015 |
Hookipa Biotech AG
 Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2014 |
Ausbildung von Farshad Guirakhoo
| University of Vienna | Doctorate Degree |
| University of Tehran | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| GEOVAX LABS, INC. | Health Technology |
| EXPRES2ION BIOTECH HOLDING AB | Health Technology |
| VAXXINITY, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
GeoVax, Inc.
GeoVax, Inc. BiotechnologyHealth Technology Part of GeoVax Labs, Inc., GeoVax, Inc. develops biotechnology and vaccines. The company is based in Smyrna, GA. GeoVax was acquired by Dauphin Technology, Inc. on October 03, 2006. The company was founded in 2001 by Harriet Latham Robinson. | Health Technology |
Sanofi Pasteur, Inc.
 Sanofi Pasteur, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Pasteur, Inc. provides vaccines for the prevention and treatment of diseases. It develops and manufactures influenza vaccine against the pandemic influenza virus. The company was founded in 1897 and is headquartered in Swiftwater, PA. | Health Technology |
Vaxess Technologies, Inc.
Vaxess Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Vaxess Technologies, Inc. provides global vaccine access distribution services. It develops a pipeline of next-generation MIMIX therapies. The firm provides MIMIX oncology and MIMIX infectious disease. The company was founded by Patrick Ho, David Kaplan, Kathryn Kosuda, Fiorenzo Omenetto, Michael Schrader and Livio Valenti in 2012 and is headquartered in Cambridge, MA. | Commercial Services |
| Acambis, Inc. | |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Health Technology |
| Responsive Bioservices LLC |
